The Winthrop P. Rockefeller Cancer Institute is seeking exceptional candidates for postdoctoral fellow recruitment. Applicants must have a PhD, MD/PhD or equivalent in cancer biology, immunooncology or immunology and research experience with in vitro and in vivo models. We are seeking highly self-motivated candidates with demonstrated ability for independent experimental design and research. Projects available to applicants include dissection of the molecular underpinnings of the tumor cell-microenvironment interactions as related to therapy resistance and immunologic adaptations of therapy-resistant tumor cells. Fellows will conduct literature reviews, validate targets and elucidate mechanisms of action. Applicants should be able to work independently in a team environment, driving projects from inception to completion. These postdoctoral fellow positions will provide an excellent career development opportunity, an interactive work environment and a learning experience to advance discovered targets into clinical development.
Successful applicants will join one of the most prestigious cancer centers in the country, world-renowned for its multiple myeloma clinical and research programs. The Winthrop P. Rockefeller Cancer Institute is the only cancer center in the state of Arkansas with a robust cancer research portfolio treating over 2,500 new cancer patients a year and supporting nearly 270 cancer clinical trials. Due to its longstanding reputation for outstanding myeloma clinical care, the Winthrop P. Rockefeller Cancer Institute offers a comprehensive human subject database with detailed baseline and follow-up data that is unsurpassed in depth and capacity to predict patient outcomes. Faculty and fellow positions will reside within the University of Arkansas for Medical Sciences Hematology/Oncology Division. Successful applicants will have the opportunity to thrive in the UAMS Myeloma Center, an intellectually stimulating and scientifically rigorous fast-paced environment providing exposure to cutting-edge approaches such as single-cell genomics, patient-derived xenograft mouse, genetic myeloma mouse, CRISPR/Cas9 genome engineering, proteomics and metabolomics. All laboratory projects are aimed at understanding how heterogeneous subpopulations of myeloma tumor cells evolve as ecosystems throughout therapy resistance. This recruitment is made possible through significant institutional support and a $10M annual commitment from the state of Arkansas to support the Cancer Institute’s efforts to attain NCI Designation.
Applicants should send a 3 page research statement, their Curriculum Vitae, a one page letter of interest, and 3 professional references to Myeloma Center Research Director, Fenghuang (Frank) Zhan, MD, PhD at firstname.lastname@example.org. Applications will be reviewed now through July 1, 2021. Selected applicants will join a diverse and vibrant academic community that values its researchers and is committed to diversity, equity and inclusion. Applicants must be able to work in a team environment.
UAMS is an inclusive Affirmative Action and Equal Opportunity Employer of individuals with disabilities and protected veterans and is committed to excellence.